This study examines the formation mechanism and patient-related factors of silent cerebral infarcts, whose importance has become increasingly recognized in patients undergoing percutaneous coronary intervention.
This study was produced from the assistant's thesis and was previously accepted as a poster at EuroPCR 2020. We recently completed the full-length article. This thesis study was supported by Ondokuzmayis University.
Study Type
OBSERVATIONAL
Enrollment
120
The Silent Brain Injury ratio was compared by measuring the Neuron-specific enzyme level with venous blood sampling from both patient groups before and after percutaneous coronary intervention.
Ondokuzmayis University
Samsun, Turkey (Türkiye)
Baseline Neuron-specific Enolase (NSE) measurement
Baseline NSE measurement to exclude non-PCI dependent brain injury. Elevation of \>20 ng/ml was considered as silent brain injury. Patients with basal nse elevation were considered as SBI and excluded from the study.
Time frame: NSE blood levels were measured 1-2 hours before the procedure.
Silent Brain Injury diagnosis
NSE blood levels were measured 12-18 hours after the procedure. Elevation of \>20 ng/ml was considered as SBI.
Time frame: 12-18 hours after percutaneous coronary intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.